JnJ COVID booster 85 percent effective against Omicron hospitalisation: SAMRC Ruchika Sharma15 Jan 2022 11:00 AM ISTJohannesburg: A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for...
Covishield 3rd dose increases antibody response against Omicron: Study Roshni Dhar14 Jan 2022 5:38 PM ISTA third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant,...
Fourth dose of mRNA-based vaccine may be warranted in some kidney transplant recipients Hina Zahid14 Jan 2022 8:15 AM ISTKidney transplant recipients receiving immunosuppressive drugs have impaired immune responses to messenger RNA (mRNA) COVID-19 vaccines ....
Moderna to report COVID vaccine data for children aged 2-5 in March Ruchika Sharma13 Jan 2022 4:35 PM ISTNew Delhi: Moderna Inc said it expects to report data from its Covid-19 vaccine trial in children aged between 2 to 5 years in March."If the data is...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
Covaxin booster dose shows neutralising effect on Omicron, Delta variants, states Study Ruchika Sharma13 Jan 2022 1:08 PM ISTNew Delhi: Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta...
USFDA warns against rare bleeding risk of JnJ COVID vaccine Ruchika Sharma12 Jan 2022 4:15 PM ISTNew Delhi: The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare...
JnJ Single shot vaccine protects against breakthrough COVID-19 for up to 6 months: Study Roshni Dhar12 Jan 2022 11:47 AM ISTJohnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and...
Moderna eyes USD 22 billion from COVID vaccine, booster sales in 2022 Ruchika Sharma12 Jan 2022 9:00 AM ISTNew Delhi: Moderna Inc said on Monday it expected to record sales of about $18.5 billion in 2022 from contracts for its COVID-19 vaccine, and...
Covaxin booster dose safe, says Bharat Biotech Ruchika Sharma11 Jan 2022 3:44 PM ISTNew Delhi: Covaxin manufacturer Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety...
Pfizer, Acuitas Therapeutics ink pact for Lipid Nanoparticle Delivery System for use in mRNA Vaccines Ruchika Sharma11 Jan 2022 10:30 AM ISTNew York: Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable...
Covid-19: UK govt advisers recommended against fourth vaccine dose Medical Dialogues Bureau10 Jan 2022 12:45 PM ISTLONDON: UK government advisers have recommended against giving a fourth dose of Covid-19 vaccine to nursing home residents and people over 80 because...
